How should a newborn with grade 3 hypoxic‑ischemic encephalopathy be managed?

Management of Grade 3 Hypoxic-Ischemic Encephalopathy

Initiate therapeutic hypothermia immediately if the infant is ≥36 weeks gestation and within 6 hours of birth, cooling to 33-34°C for 72 hours followed by controlled rewarming over at least 4 hours. This is the only proven neuroprotective intervention that reduces death and severe neurodevelopmental disability in moderate-to-severe HIE 1.

Immediate Assessment and Eligibility (Within 6 Hours)

Therapeutic hypothermia must begin within 6 hours of birth to provide neuroprotection 2, 3. Grade 3 (severe) HIE meets criteria for treatment based on:

• Gestational age: ≥36 weeks (term/near-term infants) 1
• Clinical encephalopathy: Severe findings on modified Sarnat examination (stupor/coma, absent primitive reflexes, severe hypotonia, absent or weak suck, clinical seizures) 4
• Evidence of perinatal hypoxia-ischemia: pH ≤7.0, base deficit ≥16, or need for resuscitation at birth

Critical timing: If you cannot provide therapeutic hypothermia at your facility, initiate passive cooling immediately and arrange urgent transfer to a center with NICU capabilities 2, 4.

Therapeutic Hypothermia Protocol

Cooling Phase (0-72 hours)

Target core temperature: 33-34°C for 72 hours 1

• Use either whole-body cooling or selective head cooling (both equally effective) 3
• Monitor core temperature continuously with esophageal or rectal probe
• Maintain strict temperature control—avoid both under-cooling and over-cooling
• If passive cooling during transport: Target 35-35.5°C until servo-controlled cooling available 5

Rewarming Phase (72-76+ hours)

Rewarm slowly over minimum 4 hours (0.5°C per hour) 1

• Rapid rewarming increases risk of hyperthermia and adverse outcomes
• Monitor temperature continuously during rewarming
• Target normothermia (36.5-37.5°C) post-rewarming

Seizure Management

Implement continuous EEG monitoring as soon as possible 6. Grade 3 HIE carries high seizure risk, but most electrographic seizures occur after the first few hours.

Antiseizure Medication Protocol

First-line: Phenobarbital (loading dose 20 mg/kg IV) 6, 7

• Remains the evidence-based first-line agent despite modest efficacy
• Do NOT give prophylactic antiseizure medications 4
• Treat only EEG-confirmed seizures

Second-line options (if seizures persist after phenobarbital) 6:

• Phenytoin (20 mg/kg IV)
• Levetiracetam
• Midazolam infusion
• Consider pyridoxine trial if seizures refractory to second-line agents 6

Discontinue antiseizure medications before discharge if seizures have resolved and no evidence of neonatal-onset epilepsy 6. Continuing medications does not improve neurodevelopmental outcomes.

Supportive Care Requirements

This intervention requires comprehensive NICU capabilities 1. You must have immediate access to:

Respiratory Support

• Mechanical ventilation capability
• Pulse oximetry
• Avoid both hypoxia and hyperoxia
• Manage persistent pulmonary hypertension (common complication) with inhaled nitric oxide if needed 8

Hemodynamic Management

• Expect increased need for inotropic support during cooling 1
• Maintain adequate systemic blood pressure
• Central venous access for medication administration

Metabolic Management

Avoid hypoglycemia 2, 3:

• Check glucose before 30 minutes of life 5
• Start IV glucose infusion promptly after resuscitation
• No specific target range established, but hypoglycemia worsens brain injury
• Correct hypoglycemia parenterally in severe HIE 5

Hematologic Monitoring

• Expect thrombocytopenia (common adverse effect of cooling) 2, 3
• Transfusion services must be available

Neuroimaging

• MRI is critical for prognosis (perform after rewarming, typically day 4-7)
• Ultrasound capability for initial assessment 1

Common Pitfalls to Avoid

1. Delayed cooling initiation: Every hour of delay reduces neuroprotective benefit. Start passive cooling immediately if transfer needed.

2. Temperature instability: Both inadequate cooling and overcooling reduce efficacy. Continuous core temperature monitoring is mandatory.

3. Rapid rewarming: Increases hyperthermia risk and may worsen outcomes. Minimum 4-hour rewarming period required.

4. Prophylactic antiseizure medications: Do not give—treat only confirmed seizures on EEG monitoring.

5. Attempting hypothermia without adequate resources: This causes harm 1. If you lack multidisciplinary NICU capabilities, transfer immediately.

6. Continuing antiseizure medications at discharge: Discontinue if acute provoked seizures have resolved—prolonged treatment does not improve outcomes 6.

Outcomes and Follow-up

Number needed to treat: 7 infants to prevent one case of death or severe disability 1. Therapeutic hypothermia reduces:

• Death or neurodevelopmental impairment by 33% 1
• Cerebral palsy by 48% 1
• Deafness by 58% 1

All treated infants require longitudinal neurodevelopmental follow-up 3 to screen for postneonatal epilepsy, motor disabilities, and cognitive impairment 7.

Resource-Limited Settings

In low- and middle-income countries with adequate NICU support, therapeutic hypothermia is recommended 1, 9, 1. However, this requires the full supportive care infrastructure listed above. Simple cooling methods without comprehensive monitoring and multidisciplinary care may cause harm 1.